Eli Lilly has announced it is slashing the price of Zepbound (tirzepatide) — its hugely popular GLP-1/GIP-1 weight-loss medication — and is introducing higher-dose vials of it. The initiative aims to provide more affordable options for patients paying out-of-pocket and to counter the growing market of compounded versions of weight-loss drugs. Eli Lilly has unveiled […]
News
Life Science News
Pharma News
Biotech News
Medical Device News
Healthcare News
Food News
Videos
Blogs
Life Sciences Quizzes & Polls